ea0090oc10.3 | Oral Communications 10: Diabetes, Obesity, Metabolism and Nutrition 2 | ECE2023
Masi Davide
, Zilich Rita
, Candido Riccardo
, Guaita Giacomo
, Muselli Marco
, Ponzani Paola
, Santin Pierluigi
, Verda Damiano
, Musacchio Nicoletta
Introduction: Lowering low-density lipoprotein cholesterol (LDL-C) via lifestyle change or pharmacologic therapy can reduce the cardiovascular risk (CV) in patients with type 2 diabetes (T2D). However, the response to lipid-lowering interventions is not uniform and a significant proportion of T2D patients do not reach the recommended LDL-C target. Elucidating the factors associated with lipid goal attainment represents an unmet clinical need.Material and...